Dishman Carbogen Amcis’ arm completes Swissmedic inspection of facility in Switzerland

29 Sep 2022 Evaluate

Dishman Carbogen Amcis’ wholly owned subsidiary -- Carbogen Amcis AG. has successfully completed a Swissmedic inspection, performed by Regional Medicines Inspectorate of Western Switzerland (ISOPTh), of its facility in Vionnaz, Switzerland.

The two-day inspection took place from September 20 to 21, 2022 and was undertaken by an inspector of Regional Medicines Inspectorate of Western Switzerland (ISOPTh) at the Vionnaz, Switzerland site. The routine inspection covered the Quality Management System compliance and no critical deviation was raised. This inspection continues a series of successful inspections by Swissmedic in Vionnaz with the first inspection in 2015 followed by 2016, 2017 and 2020.

Dishman Carbogen Amcis provides innovative solutions for the development and supply of drug substances and drug products to the pharmaceutical and biopharmaceutical industries.

Dishman Carbogen Amc Share Price

223.15 -5.45 (-2.38%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×